NCT04778878View on ClinicalTrials.gov

Assessment of Chemotherapy-induced Peripheral Neurotoxicity Using a Point-of-care Nerve Conduction Study Device

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
Cancer
Interventions
DEVICE

Mediracer® NCS

A point-of-care, hand-held nerve conduction device

Trial Locations (1)

Unknown

Oulu University Hospital, Oulu

All Listed Sponsors
lead

Oulu University Hospital

OTHER

NCT04778878 - Assessment of Chemotherapy-induced Peripheral Neurotoxicity Using a Point-of-care Nerve Conduction Study Device | Biotech Hunter | Biotech Hunter